| Original language | English |
|---|---|
| Publication status | Published - May 2022 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Investigating the use of Keap1-Nrf2 disruptors for neuroprotection in Alzheimer’s disease
- Mohamed Elsharkasi
- , Geoffrey Wells
- , Fiona Kerrr
Research output: Contribution to conference › Poster